How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

New 2022 ASAS/EULAR Recommendations on the Management of Axial Spond…

RheumNow

S. Ramiro

High Level View of the Approach to Psoriatic Disease Treatment

Masterclasses in Dermatology

J. Merola

PsA for the Dermatologist

Masterclasses in Dermatology

J. Merola, A. Gottlieb

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Sex Matters: Gender Differences in PsA Outcomes & Management

RheumNow

L. Eder

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

2022 GRAPPA Treatment Recommendations

Laura Coates

Axial Spondyloarthritis: What Are the New Treatment Guidelines and B…

Marina Magrey

GRAPPA 2024 Debate- Managing MSK Symptoms in PsO Patients: Who Shoul…

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

F. Proft

Hard Decisions: HSV and RSV Update for Rheumatology

RheumNow

K. Winthrop

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

RheumNow

G. Valenzuela

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

EULAR 2023 Insights: The Role of Observational Data When Studying Sa…

EULAR 2023 Insights

A. Strangfeld

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

Aims & Outcomes of Therapy in Ankylosing Spondylitis: What Are the A…

Keck School of Medicine of USC

N. Patel